January-June
2001 |
PERCENT (%) RESISTANCE
TO SELECTED ANTIBIOTICS BY HOSPITAL
|
|
Acinetobacter spp |
|
Ceftazidime (all clinical specimens) |
|
Amikacin (all clinical specimens) |
|
Ciprofloxacin (all clinical specimens) |
|
Imipenem (all clinical specimens) |
|
Multiresistance (all clinical specimens, basic statistics) |
|
Blood isolates (results from all hospitals) |
Pseudomonas aeruginosa |
|
Ceftazidime (all clinical specimens) |
|
Amikacin (all clinical specimens) |
|
Ciprofloxacin (all clinical specimens) |
|
Imipenem (all clinical specimens) |
|
Multiresistance (all clinical specimens, basic statistics) |
|
Blood isolates (results from all hospitals) |
Enterobacter spp |
|
Ceftazidime (all clinical specimens) |
|
Tobramycin (all clinical specimens) |
|
Ciprofloxacin (all clinical specimens) |
|
Multiresistance (all clinical specimens, basic statistics) |
|
Blood isolates (results from all hospitals) |
S. aureus |
|
% MRSA by hospital (all clinical specimens, basic statistics) |
|
% MRSA to Gentamicin (all clinical specimens, basic statistics)
|
|
Blood isolates (results from all hospitals) |
Coagulase Negative Staphylococci
|
|
Methicilin (all clinical specimens, basic
statistics) |
|
Gentamicin and Methicilin
(all clinical specimens, basic statistics)
|
|
Blood isolates (results from all hospitals) |
Klebsiella pneumoniae |
|
Ceftazidime (all clinical specimens) |
|
Cefoxitin (all clinical specimens) |
|
Ciprofloxacin (all clinical specimens) |
|
Tobramycin (all clinical specimens) |
|
Multiresistance (all clinical specimens, basic statistics) |
|
Blood isolates (results from all hospitals) |
Enterococci |
|
Vancomycin (all clinical specimens, basic statistics) |
|
Blood isolates (results from all hospitals) |
E. coli |
|
Blood isolates (results from all hospitals) |
|
DISTRIBUTION OF BACTERIAL SPECIES
|
All clinical specimens |
|
Bacterial species by hospital (wards) |
|
Bacterial species by hospital (ICU) |
Blood cultures |
|
Isolated microorganisms by
type of ward |